IGF2 and neoplasm: Interestingly, in hepatocarcinoma cells, miR-493-5p displayed anti-tumor activity by inhibiting the IGF2-derived intronic miR-483-3p, the expression of which correlates with IGF2-LOI in liver cancer cells [126].